Part Used : ไม่ระบุ
Activity : HEMORRHAGIC EFFECT
Solvent/Active Compound :
Type of experiment : non specified
Type of animal : -
N(Total) : -
N(Treatment) : -
Route : Non-specified
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : Lisinopril
Dose/Conc.(drug) : -
Remark : Reduction of CYP2E1 activity in humans and some animal species; no increase in CYP2B1/2 in humans. Mild inhibition of Pgp in vitro. Single reports of increased bleeding time with lisinopril, warfarin. Reduces bioavailability of the protease inhibitor saquinavir and to a lesser extent ritonavir. Appears safe with most drugs except saquinavir.
Note : Data from review, data incomplete.